Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Sept 2026 for Marvel Biosciences Corp. Formerly Alphanco Venture Corp..
Filing timeline
BuySaleNeil Allan Johnson
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Neil Allan Johnson: trading record in brief
Neil Allan Johnson appears in our data through filings on Marvel Biosciences Corp. Formerly Alphanco Venture Corp. shares, published by SEDI. The record holds 9 filings, for trades running from 14 June 2021 to 1 September 2026.
Purchases make up the whole of the open-market record (1 purchase, €3,649). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant.
The newest entry dates from 1 September 2026: a share grant, in Marvel Biosciences Corp. Formerly Alphanco Venture Corp. The last purchase on record was published on 20 August 2024, which is 797 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 6 days. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Neil Allan Johnson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
16,667 sharesDeferred Share UnitsTSXSEDI:4770734
Common SharesTSXSEDI:4497176
Common SharesTSXSEDI:4497178
80,000 shares@ CA$0.12513.3% of flowCommon SharesTSXSEDI:4497152
200,000 shares@ CA$0.12533.2% of flowCommon SharesTSXSEDI:4497180
323,000 shares@ CA$0.12553.6% of flowCommon SharesTSXSEDI:4497177
50,000 shares@ CA$0.11Common SharesTSXSEDI:4364045
Canonical exit: 14 Nov 2024 (T+90)
250,000 shares@ CA$0.10Common SharesTSXSEDI:3979956
Common SharesTSXSEDI:3778159
9 of 9 declarations
